Rebekka Jerjen, Nekma Meah, Lara Trindade de Carvalho, Dmitri Wall, Shyamalar Gunatheesan, Rodney Sinclair
{"title":"Effective treatment of folliculitis decalvans with cyclosporin: A case series.","authors":"Rebekka Jerjen, Nekma Meah, Lara Trindade de Carvalho, Dmitri Wall, Shyamalar Gunatheesan, Rodney Sinclair","doi":"10.1111/ajd.13532","DOIUrl":null,"url":null,"abstract":"Folliculitis decalvans is a neutrophilic cicatricial alopecia that preferentially affects the scalp vertex and occiput. Therapy aims to arrest inflammation and prevent hair loss. Response to antibiotic and anti-inflammatory treatments is unpredictable, resulting in a sometimes chronic, recalcitrant course. We report three patients with refractory folliculitis decalvans responding to cyclosporin. In the absence of a validated outcome measure for folliculitis decalvans, we considered photographic and symptomatic improvement; maintenance of the same therapeutic dose; and ability to taper therapy in assessing treatment response.","PeriodicalId":243138,"journal":{"name":"The Australasian journal of dermatology","volume":" ","pages":"e345-e347"},"PeriodicalIF":0.0000,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/ajd.13532","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Australasian journal of dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ajd.13532","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/6 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Folliculitis decalvans is a neutrophilic cicatricial alopecia that preferentially affects the scalp vertex and occiput. Therapy aims to arrest inflammation and prevent hair loss. Response to antibiotic and anti-inflammatory treatments is unpredictable, resulting in a sometimes chronic, recalcitrant course. We report three patients with refractory folliculitis decalvans responding to cyclosporin. In the absence of a validated outcome measure for folliculitis decalvans, we considered photographic and symptomatic improvement; maintenance of the same therapeutic dose; and ability to taper therapy in assessing treatment response.